Interaction Propensity
Strongest directed Tier 1 cell-ontology contact preference per sample. Bulk files are centralized on the Download page.
101-150 of 2,070
Interaction Propensity
Strongest directed Tier 1 cell-ontology contact preference per sample.
2,069 ready
| Sample | Organ | Disease state | Cells | Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. | Direction | Propensity | FDR |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_A7,10 | Lung | Primary cancer | 1,550 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.90 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A7,11 | Lung | Primary cancer | 3,752 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.78 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A7,12 | Lung | Primary cancer | 2,771 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.92 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A7,13 | Lung | Primary cancer | 1,886 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.75 | 1.76e-2 |
| NSCLC_38242124__IMC__175_A7,14 | Lung | Primary cancer | 3,114 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.72 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A7,15 | Lung | Primary cancer | 3,645 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.12 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A7,16 | Lung | Primary cancer | 3,722 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.95 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A7,17 | Lung | Primary cancer | 2,708 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.71 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A7,2 | Lung | Primary cancer | 5,150 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.03 | 2.26e-2 |
| NSCLC_38242124__IMC__175_A7,3 | Lung | Primary cancer | 875 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.45 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A7,4 | Lung | Primary cancer | 2,282 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.18 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A7,5 | Lung | Primary cancer | 3,115 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.53 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A7,6 | Lung | Primary cancer | 4,618 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.47 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A7,7 | Lung | Primary cancer | 3,440 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.23 | 9.90e-3 |
| NSCLC_38242124__IMC__175_A7,8 | Lung | Primary cancer | 3,067 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.68 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A7,9 | Lung | Primary cancer | 3,130 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.25 | 1.58e-2 |
| NSCLC_38242124__IMC__175_A8,1 | Lung | Primary cancer | 2,832 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.87 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A8,10 | Lung | Primary cancer | 1,656 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.14 | 1.58e-2 |
| NSCLC_38242124__IMC__175_A8,11 | Lung | Primary cancer | 2,245 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.92 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A8,12 | Lung | Primary cancer | 3,487 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.94 | 1.22e-2 |
| NSCLC_38242124__IMC__175_A8,13 | Lung | Primary cancer | 2,819 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.61 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A8,14 | Lung | Primary cancer | 3,301 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.67 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A8,15 | Lung | Primary cancer | 3,533 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.77 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A8,16 | Lung | Primary cancer | 3,319 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.83 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A8,17 | Lung | Primary cancer | 2,542 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.80 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A8,2 | Lung | Primary cancer | 4,657 | Stromal -> Stromal | Enriched | 5.23 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A8,3 | Lung | Primary cancer | 2,796 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.97 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A8,4 | Lung | Primary cancer | 2,444 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.02 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A8,5 | Lung | Primary cancer | 3,198 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.40 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A8,6 | Lung | Primary cancer | 5,540 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.47 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A8,7 | Lung | Primary cancer | 4,852 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.70 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A8,8 | Lung | Primary cancer | 2,748 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.52 | 1.58e-2 |
| NSCLC_38242124__IMC__175_A8,9 | Lung | Primary cancer | 2,887 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.77 | 1.76e-2 |
| NSCLC_38242124__IMC__175_B1,1 | Lung | Primary cancer | 2,779 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.85 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B1,10 | Lung | Primary cancer | 2,759 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.03 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B1,11 | Lung | Primary cancer | 3,245 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.83 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B1,12 | Lung | Primary cancer | 3,822 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.75 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B1,13 | Lung | Primary cancer | 2,076 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.30 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B1,14 | Lung | Primary cancer | 3,300 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.74 | 1.76e-2 |
| NSCLC_38242124__IMC__175_B1,15 | Lung | Primary cancer | 2,725 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.38 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B1,16 | Lung | Primary cancer | 2,528 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.38 | 1.44e-2 |
| NSCLC_38242124__IMC__175_B1,17 | Lung | Primary cancer | 1,429 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.23 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B1,2 | Lung | Primary cancer | 2,305 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.25 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B1,3 | Lung | Primary cancer | 4,171 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.55 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B1,4 | Lung | Primary cancer | 2,713 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.90 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B1,5 | Lung | Primary cancer | 3,623 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.91 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B1,6 | Lung | Primary cancer | 3,146 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.04 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B1,7 | Lung | Primary cancer | 3,665 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.68 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B1,8 | Lung | Primary cancer | 2,860 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.87 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B1,9 | Lung | Primary cancer | 4,697 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.38 | 1.06e-2 |